Mimedx (MDXG) Non-Current Assets (2010 - 2026)

Mimedx (MDXG) reported Non-Current Assets of $68.4 million for Q1 2026, down 2.78% on a YoY basis from $70.3 million in Q1 2025, and up 4.86% sequentially from $65.2 million in Q4 2025.

Mimedx (MDXG) Non-Current Assets (2010 - 2026) Analysis & Trends

Mimedx (MDXG) has 17 years of Non-Current Assets data on file, last reported at $68.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 2.78% year-over-year to $68.4 million; the trailing twelve-month figure through Mar 2026 stood at $268.7 million (down 7.44% YoY), and the FY2025 full-year result was $65.2 million, down 9.51% from the prior year.
  • Non-Current Assets advanced to $68.4 million in Q1 2026, from $65.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $82.8 million in Q1 2024 to a low of $34.5 million in Q3 2023.
  • A 5-year average of $57.2 million and a median of $65.2 million in 2025 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets jumped 127.19% in 2024 and retreated 15.12% in 2025, its largest moves.
  • Tracing MDXG's Non-Current Assets over 5 years: stood at $37.2 million in 2022, then jumped by 100.86% to $74.8 million in 2023, then retreated by 3.69% to $72.0 million in 2024, then dropped by 9.51% to $65.2 million in 2025, then gained by 4.86% to $68.4 million in 2026.
  • Business Quant data shows MDXG's Non-Current Assets at $68.4 million in Q1 2026, $65.2 million in Q4 2025, and $64.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Mimedx 615.09 Mn 455.31 Mn 41.62 Mn 68.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68.35 Mn
Dec 31, 2025 65.18 Mn
Sep 30, 2025 64.89 Mn
Jun 30, 2025 70.23 Mn
Mar 31, 2025 70.31 Mn
Dec 31, 2024 72.03 Mn
Sep 30, 2024 71.75 Mn
Jun 30, 2024 76.17 Mn
Mar 31, 2024 82.83 Mn
Dec 31, 2023 74.79 Mn
Sep 30, 2023 34.52 Mn
Jun 30, 2023 35.16 Mn
Mar 31, 2023 36.46 Mn
Dec 31, 2022 37.23 Mn
Sep 30, 2022 36.76 Mn
Jun 30, 2022 37.66 Mn
Mar 31, 2022 38.54 Mn
Dec 31, 2021 39.41 Mn
Sep 30, 2021 38.62 Mn
Jun 30, 2021 39.46 Mn